SAN DIEGO, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Cue Health Inc. (Cue) announced today that, as of November 9, the U.S. Department of Health and Human Services (HHS) began deploying its molecular, ...

Cue Health developed a rapid COVID-19 test that's become the new gold standard: fast, reliable, and easy to use. The company is now getting ready to IPO.

SAN DIEGO--(BUSINESS WIRE)--Cue Health (Nasdaq: HLTH), a healthcare technology company, today announced that it has been awarded a new approximately $28 million contract by the Biomedical Advanced ...

SAN DIEGO--(BUSINESS WIRE)--Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, today announced it has received Emergency Use Authorization (EUA) from the United States Food and Drug ...

The Cue Health Monitoring System has many new tests on the way, and we’re very excited about the progress and our key priority of menu expansion. We’re also happy to see the peer-review publication of ...

San Diego-based Cue Health, a developer of rapid molecular testing products, has raised $100M in a Series C funding round, the company said this week. The funding came from Decheng Capital, Foresite ...

Cue Health, a San Diego biotech that ascended during the pandemic through mega funding and partnerships for its rapid COVID-19 test, said Wednesday that it is laying off half of its workforce as it ...

Cue Health, a San Diego-based medical tech company, announced Wednesday that it’s laying off about half of its already-sharply shrunken workforce. Cue spokesperson Jessie Wick told SFGATE in an email ...